From the youngest patients to the oldest, the Affordable Care Act's promise that care will be provided despite pre-existing conditions is bumping against the challenge of keeping costs in check. From around the country come reports of pushback, which evoke the 1990s stories of managed care's debut: limited choice.
From the youngest patients to the oldest, the Affordable Care Act (ACA)’s promise that care will be provided despite pre-existing conditions is bumping against the challenge of keeping costs in check. From around the country come reports of pushback, which evoke the 1990s stories of managed care’s debut: limited choice.
To be sure, the stated commitment today is that cost is not the first concern, quality is. But that doesn’t mean that there aren’t some high-profile examples of premier institutions being left off certain plans for reasons of cost containment. Of note:
During a recent call with investors, Aetna CEO Mark Bertolini described the backlash from consumers over the issue, and he said “doc shock” would be a major issue. Insurers do respond he said, because if they are pressured to add to networks, prices are affected. The push and pull of whether to include certain providers will continue in the early years of the ACA and will affect the ability of insurers to keep prices down, experts have predicted, much the same as the early years of managed care.
The difference this time, of course, is the challenge for accountable care organizations to meet targets from CMS on population health, patient satisfaction and cost savings. Those last two would seem to be at odds—if high-cost providers are not included, patients might not be pleased, but allowing them in the network might hurt the cause of meeting savings goals.
Academic centers are pointing out that not all hospitals are the same; those specialized care centers that take the most difficult cases are, by definition, going to consume more healthcare costs, and this must be taken into account.
Around the Web
Do State Officials Have Authority Over Medicare Advantage Insurers?
Left Off Many Networks, Seattle Children’s Sues
Real-World Study Reveals Key Insights into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Collecting SDOH Data Can Assess Risk of Medical Nonadherence, Improve HEI and Star Ratings
April 18th 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, a panel of presenters explored changes coming to Medicare that incorporate social determinants of health (SDOH) data to improve patient and health system outcomes.
Read More